SEC Form 4 · accession 0001179110-15-004509
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Wysenski
Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock OptionF1 | $7.56 | Mar 5, 2015 | A | 18,750 | A | Mar 5, 2015 | Mar 5, 2025 | Common Stock | 18,750 | 18,750 | D |
Explanation of responses
- F1These 18,750 options will vest in equal installments quarterly over three years.